321 related articles for article (PubMed ID: 12914700)
1. Histone H2AX: a dosage-dependent suppressor of oncogenic translocations and tumors.
Bassing CH; Suh H; Ferguson DO; Chua KF; Manis J; Eckersdorff M; Gleason M; Bronson R; Lee C; Alt FW
Cell; 2003 Aug; 114(3):359-70. PubMed ID: 12914700
[TBL] [Abstract][Full Text] [Related]
2. Aberrant V(D)J recombination is not required for rapid development of H2ax/p53-deficient thymic lymphomas with clonal translocations.
Bassing CH; Ranganath S; Murphy M; Savic V; Gleason M; Alt FW
Blood; 2008 Feb; 111(4):2163-9. PubMed ID: 17855626
[TBL] [Abstract][Full Text] [Related]
3. H2AX prevents DNA breaks from progressing to chromosome breaks and translocations.
Franco S; Gostissa M; Zha S; Lombard DB; Murphy MM; Zarrin AA; Yan C; Tepsuporn S; Morales JC; Adams MM; Lou Z; Bassing CH; Manis JP; Chen J; Carpenter PB; Alt FW
Mol Cell; 2006 Jan; 21(2):201-14. PubMed ID: 16427010
[TBL] [Abstract][Full Text] [Related]
4. Histone H2AX suppresses translocations in lymphomas of Eμ-c-Myc transgenic mice that contain a germline amplicon of tumor-promoting genes.
Fusello A; Horowitz J; Yang-Iott K; Brady BL; Yin B; Rowh MA; Rappaport E; Bassing CH
Cell Cycle; 2013 Sep; 12(17):2867-75. PubMed ID: 23966158
[TBL] [Abstract][Full Text] [Related]
5. H2AX haploinsufficiency modifies genomic stability and tumor susceptibility.
Celeste A; Difilippantonio S; Difilippantonio MJ; Fernandez-Capetillo O; Pilch DR; Sedelnikova OA; Eckhaus M; Ried T; Bonner WM; Nussenzweig A
Cell; 2003 Aug; 114(3):371-383. PubMed ID: 12914701
[TBL] [Abstract][Full Text] [Related]
6. Cellular context-dependent effects of H2ax and p53 deletion on the development of thymic lymphoma.
Yin B; Yang-Iott KS; Chao LH; Bassing CH
Blood; 2011 Jan; 117(1):175-85. PubMed ID: 20947684
[TBL] [Abstract][Full Text] [Related]
7. 53BP1 cooperates with p53 and functions as a haploinsufficient tumor suppressor in mice.
Ward IM; Difilippantonio S; Minn K; Mueller MD; Molina JR; Yu X; Frisk CS; Ried T; Nussenzweig A; Chen J
Mol Cell Biol; 2005 Nov; 25(22):10079-86. PubMed ID: 16260621
[TBL] [Abstract][Full Text] [Related]
8. Tp53 deletion in B lineage cells predisposes mice to lymphomas with oncogenic translocations.
Rowh MA; DeMicco A; Horowitz JE; Yin B; Yang-Iott KS; Fusello AM; Hobeika E; Reth M; Bassing CH
Oncogene; 2011 Nov; 30(47):4757-64. PubMed ID: 21625223
[TBL] [Abstract][Full Text] [Related]
9. Redundant and nonredundant functions of ATM and H2AX in αβ T-lineage lymphocytes.
Yin B; Lee BS; Yang-Iott KS; Sleckman BP; Bassing CH
J Immunol; 2012 Aug; 189(3):1372-9. PubMed ID: 22730535
[TBL] [Abstract][Full Text] [Related]
10. Oncogenic transformation in the absence of Xrcc4 targets peripheral B cells that have undergone editing and switching.
Wang JH; Alt FW; Gostissa M; Datta A; Murphy M; Alimzhanov MB; Coakley KM; Rajewsky K; Manis JP; Yan CT
J Exp Med; 2008 Dec; 205(13):3079-90. PubMed ID: 19064702
[TBL] [Abstract][Full Text] [Related]
11. Functional interaction of H2AX, NBS1, and p53 in ATM-dependent DNA damage responses and tumor suppression.
Kang J; Ferguson D; Song H; Bassing C; Eckersdorff M; Alt FW; Xu Y
Mol Cell Biol; 2005 Jan; 25(2):661-70. PubMed ID: 15632067
[TBL] [Abstract][Full Text] [Related]
12. Genetic pathway to recurrent chromosome translocations in murine lymphoma involves V(D)J recombinase.
Vanasse GJ; Halbrook J; Thomas S; Burgess A; Hoekstra MF; Disteche CM; Willerford DM
J Clin Invest; 1999 Jun; 103(12):1669-75. PubMed ID: 10377173
[TBL] [Abstract][Full Text] [Related]
13. Histone H2AX stabilizes broken DNA strands to suppress chromosome breaks and translocations during V(D)J recombination.
Yin B; Savic V; Juntilla MM; Bredemeyer AL; Yang-Iott KS; Helmink BA; Koretzky GA; Sleckman BP; Bassing CH
J Exp Med; 2009 Nov; 206(12):2625-39. PubMed ID: 19887394
[TBL] [Abstract][Full Text] [Related]
14. Combined deletion of Xrcc4 and Trp53 in mouse germinal center B cells leads to novel B cell lymphomas with clonal heterogeneity.
Chen Z; Elos MT; Viboolsittiseri SS; Gowan K; Leach SM; Rice M; Eder MD; Jones K; Wang JH
J Hematol Oncol; 2016 Jan; 9():2. PubMed ID: 26740101
[TBL] [Abstract][Full Text] [Related]
15. Evidence for replicative repair of DNA double-strand breaks leading to oncogenic translocation and gene amplification.
Difilippantonio MJ; Petersen S; Chen HT; Johnson R; Jasin M; Kanaar R; Ried T; Nussenzweig A
J Exp Med; 2002 Aug; 196(4):469-80. PubMed ID: 12186839
[TBL] [Abstract][Full Text] [Related]
16. 53BP1 and p53 synergize to suppress genomic instability and lymphomagenesis.
Morales JC; Franco S; Murphy MM; Bassing CH; Mills KD; Adams MM; Walsh NC; Manis JP; Rassidakis GZ; Alt FW; Carpenter PB
Proc Natl Acad Sci U S A; 2006 Feb; 103(9):3310-5. PubMed ID: 16492765
[TBL] [Abstract][Full Text] [Related]
17. Artemis and p53 cooperate to suppress oncogenic N-myc amplification in progenitor B cells.
Rooney S; Sekiguchi J; Whitlow S; Eckersdorff M; Manis JP; Lee C; Ferguson DO; Alt FW
Proc Natl Acad Sci U S A; 2004 Feb; 101(8):2410-5. PubMed ID: 14983023
[TBL] [Abstract][Full Text] [Related]
18. Unrepaired DNA breaks in p53-deficient cells lead to oncogenic gene amplification subsequent to translocations.
Zhu C; Mills KD; Ferguson DO; Lee C; Manis J; Fleming J; Gao Y; Morton CC; Alt FW
Cell; 2002 Jun; 109(7):811-21. PubMed ID: 12110179
[TBL] [Abstract][Full Text] [Related]
19. Role of genomic instability and p53 in AID-induced c-myc-Igh translocations.
Ramiro AR; Jankovic M; Callen E; Difilippantonio S; Chen HT; McBride KM; Eisenreich TR; Chen J; Dickins RA; Lowe SW; Nussenzweig A; Nussenzweig MC
Nature; 2006 Mar; 440(7080):105-9. PubMed ID: 16400328
[TBL] [Abstract][Full Text] [Related]
20. H2AX may function as an anchor to hold broken chromosomal DNA ends in close proximity.
Bassing CH; Alt FW
Cell Cycle; 2004 Feb; 3(2):149-53. PubMed ID: 14712078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
